Matinas BioPharma
MTNB
MTNB
31 hedge funds and large institutions have $6.6M invested in Matinas BioPharma in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 10 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
70% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 10
Holders
31
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$116K | |
| 2 | +$70.3K | |
| 3 | +$44.4K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$18.3K |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$10.7K |
Top Sellers
| 1 | -$138K | |
| 2 | -$137K | |
| 3 | -$87K | |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
-$86K |
| 5 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$72.8K |